BG47647A3 - Method for preparing of phenothiazinic derivatives - Google Patents

Method for preparing of phenothiazinic derivatives

Info

Publication number
BG47647A3
BG47647A3 BG063286A BG6328683A BG47647A3 BG 47647 A3 BG47647 A3 BG 47647A3 BG 063286 A BG063286 A BG 063286A BG 6328683 A BG6328683 A BG 6328683A BG 47647 A3 BG47647 A3 BG 47647A3
Authority
BG
Bulgaria
Prior art keywords
derivatives
phenothiazinic
preparing
drowsiness
morbid
Prior art date
Application number
BG063286A
Other languages
Bulgarian (bg)
English (en)
Inventor
Geoffrey Coker
John Addison
Harry Leighton
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838318832A external-priority patent/GB8318832D0/en
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of BG47647A3 publication Critical patent/BG47647A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/20[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG063286A 1982-12-02 1983-12-01 Method for preparing of phenothiazinic derivatives BG47647A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8234398 1982-12-02
GB838318832A GB8318832D0 (en) 1983-07-12 1983-07-12 Chemical compounds

Publications (1)

Publication Number Publication Date
BG47647A3 true BG47647A3 (en) 1990-08-15

Family

ID=26284560

Family Applications (2)

Application Number Title Priority Date Filing Date
BG063286A BG47647A3 (en) 1982-12-02 1983-12-01 Method for preparing of phenothiazinic derivatives
BG088609A BG50158A3 (en) 1982-12-02 1983-12-01 Method for preparing derivatives of phenothiazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG088609A BG50158A3 (en) 1982-12-02 1983-12-01 Method for preparing derivatives of phenothiazine

Country Status (22)

Country Link
EP (1) EP0117302B1 (ja)
JP (1) JPH06767B2 (ja)
KR (1) KR890000638B1 (ja)
AU (1) AU572105B2 (ja)
BG (2) BG47647A3 (ja)
CA (1) CA1280749C (ja)
DD (1) DD213922A5 (ja)
DE (1) DE3381689D1 (ja)
DK (1) DK551283A (ja)
ES (7) ES527705A0 (ja)
FI (1) FI81788C (ja)
GR (1) GR81958B (ja)
HU (1) HU193274B (ja)
IE (1) IE56998B1 (ja)
IL (2) IL70359A (ja)
MC (1) MC1562A1 (ja)
NO (1) NO160203C (ja)
NZ (1) NZ206458A (ja)
PH (1) PH20433A (ja)
PL (2) PL145778B1 (ja)
PT (1) PT77766B (ja)
YU (1) YU44758B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413915D0 (en) * 1984-05-31 1984-07-04 Wellcome Found Phenothiazine compounds
JPS6256489A (ja) * 1985-09-04 1987-03-12 Sanwa Kagaku Kenkyusho:Kk 新規なピロリチジン化合物及びその塩、これらの製法並びにこれらを有効成分とする消化性潰瘍治療剤
US6333322B1 (en) 1996-03-13 2001-12-25 Eisai Co., Ltd. Nitrogen-containing tricyclic compounds and drugs containing the same
EP2229590B1 (en) 2007-12-10 2018-11-21 Ascensia Diabetes Care Holdings AG Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator
EP2758403B1 (en) 2011-09-21 2016-04-27 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
KR101646962B1 (ko) 2014-09-29 2016-08-10 한국과학기술연구원 CaM 저해활성을 가지는 페노싸이아진 유도체
US10035795B1 (en) 2017-04-06 2018-07-31 Korea Institute Of Science And Technology Phenothiazine derivatives having CaM inhibitory activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956996A (en) * 1960-10-18 Alkylated phenotfflazenecarboxamede
NL97951C (ja) * 1955-11-15
NL96990C (ja) * 1956-01-10
NL58901C (ja) * 1957-02-07 1947-02-15
NL273878A (ja) * 1961-01-24
US3112310A (en) * 1962-01-15 1963-11-26 Searle & Co 10-alkylaminoalkylphenothiazine-2-carboxamides

Also Published As

Publication number Publication date
DK551283A (da) 1984-06-03
FI834401A0 (fi) 1983-12-01
FI834401A (fi) 1984-06-03
PH20433A (en) 1987-01-05
IE832825L (en) 1984-06-02
CA1280749C (en) 1991-02-26
PL252163A1 (en) 1985-11-05
MC1562A1 (fr) 1984-11-12
DK551283D0 (da) 1983-12-01
PL145778B1 (en) 1988-10-31
PT77766B (en) 1986-05-30
ES534353A0 (es) 1985-07-16
ES534354A0 (es) 1985-07-16
BG50158A3 (en) 1992-05-15
JPS59110684A (ja) 1984-06-26
HU193274B (en) 1987-09-28
IE56998B1 (en) 1992-03-11
ES8506672A1 (es) 1985-07-16
NZ206458A (en) 1987-07-31
DE3381689D1 (de) 1990-08-02
YU44758B (en) 1991-02-28
ES8506296A1 (es) 1985-07-01
ES8506675A1 (es) 1985-08-01
ES8506676A1 (es) 1985-07-16
JPH06767B2 (ja) 1994-01-05
ES534358A0 (es) 1985-07-16
DD213922A5 (de) 1984-09-26
PT77766A (en) 1984-01-01
IL70359A (en) 1988-05-31
AU572105B2 (en) 1988-05-05
EP0117302A3 (en) 1984-10-17
ES534356A0 (es) 1985-07-01
IL70359A0 (en) 1984-03-30
EP0117302B1 (en) 1990-06-27
AU2190083A (en) 1984-06-07
EP0117302A2 (en) 1984-09-05
YU234983A (en) 1986-02-28
ES8504752A1 (es) 1985-04-16
PL252164A1 (en) 1985-11-19
ES534357A0 (es) 1985-08-01
FI81788C (fi) 1990-12-10
KR890000638B1 (ko) 1989-03-22
ES534355A0 (es) 1985-07-16
ES8506673A1 (es) 1985-07-16
FI81788B (fi) 1990-08-31
NO160203C (no) 1989-03-22
NO834424L (no) 1984-06-04
KR840006996A (ko) 1984-12-04
NO160203B (no) 1988-12-12
ES527705A0 (es) 1985-04-16
GR81958B (ja) 1984-12-12
ES8506674A1 (es) 1985-07-16

Similar Documents

Publication Publication Date Title
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
BG44538A3 (en) Method for preparing salts of 5- metoxy- 2- big bracket [(4- metoxy- 3, 5- dimethyl- 2- pyridinyl)- methyl] sulphonyl- 1h- benzimidazol
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
DE3853546D1 (de) Vorrichtung zum Positionieren von Gliedmassen von Patienten und torischer chirurgischer Schild.
IT8367922A0 (it) Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato
PT72435A (en) Process for the preparation of 2-/2-(1,4-benzodioxanyl)/-2-imidazoline and salts there of having pharmaceutical effect
NO833279L (no) Farmasoeytiske preparater for behandling av uoensket sammenvoksing
BG43692A3 (en) Method for preparing of 6, 16- dimethylcorticoids
BG47647A3 (en) Method for preparing of phenothiazinic derivatives
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
FI832879A0 (fi) Foerfarande foer framstaellning av cellulosaderivat med oenskad loesningsviskositet
FR2520379B1 (fr) Procede de preparation d'un disaccharide-tripeptide et d'un disaccharide-tetrapeptide possedant des proprietes immunostimulantes
IL95412A0 (en) Pharmaceutical compositions containing 5-methyl-isoxazole-4-carboxylic acid anilide derivatives and 2-hydroxy-ethylidene-cyano acetic acid anilide derivatives
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
IE810276L (en) Phenylpiperazine derivatives of oxadiazoles
ATE130192T1 (de) Verwendung von 15-deoxyspergualin als arzneimittel.
ZA83856B (en) Thiazaspirane derivatives,processes for their preparation,and medicaments
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
SE8300711L (sv) Mjoldrygealkaloider, forfarande for framstellning derav liksom farmaceutiska beredningar innehallande dessa foreningar
BE854265A (fr) Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires
FI830245A0 (fi) Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner
BG44874A3 (bg) Метод за получаване на кондензирани аs-триазини
ATE66811T1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.